You are here

Article Text

Article menu
Download PDFPDF
Miscellaneous
Research letter
Trend of main STIs during COVID-19 pandemic in Milan, Italy
  1. Marco Cusini1,
  2. Susanna Benardon2,
  3. Gianmarino Vidoni2,
  4. Livia Brignolo2,
  5. Stefano Veraldi1,
  6. Pier Luca Mandolini1
  1. 1 La Fondazione IRCCS Ca" Granda Ospedale Maggiore di Milano Policlinico, Milano, Italy
  2. 2 Dipartimento Igiene e Sanità Pubblica, MTS, Viale Jenner 44, ATS Milano Città Metropolitana, Milano, Lombardia, Italy
  1. Correspondence to Dr Marco Cusini, La Fondazione IRCCS Ca" Granda Ospedale Maggiore di Milano Policlinico, Milano, Italy; marco.cusini{at}policlinico.mi.it

https://doi.org/10.1136/sextrans-2020-054608

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    The outbreak of the COVID-19 pandemic (caused by SARS-CoV-2) is a public health emergency of magnitude.1 The rapid spread of the novel coronavirus in such a densely populated area as Lombardy threatened the capacity of the health system. All health facilities were reorganised to contain the spread of the virus. Unprecedented social isolation measures (lockdown) were adopted to control the epidemic.2 In relation to sexual health, one would assume that the lockdown should reduce the opportunity for sexual encounters and acquisition opportunities for STIs. In Milan, the main city of the Lombardy region, there are two main STI centres which account for about 80% of STI diagnosis. On 8 March, regional ordinance limited outpatient activity to acute cases only. The two STI centres remained open for ‘emergencies’. Patients …

    View Full Text

    Footnotes

    • Handling editor Anna Maria Geretti

    • Contributors All authors equally contributed in collecting data.

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Competing interests None declared.

    • Patient consent for publication Not required.

    • Provenance and peer review Not commissioned; externally peer reviewed.